Etretinate Treatment of the Nevoid Basal Cell Carcinoma Syndrome
- 1 November 1987
- journal article
- case report
- Published by Wiley in International Journal of Dermatology
- Vol. 26 (9) , 606-609
- https://doi.org/10.1111/j.1365-4362.1987.tb02319.x
Abstract
A patient suffering from the nevoid basal cell carcinoma syndrome, in whom various surgical and conservative treatment modalities had been tried previously, was placed on oral etretinate therapy. A therapeutic effect of the etretinate on existing basal cell carcinomas and a prophylactic effect in inhibiting new tumor formation were well demonstrated during the T3‐montri period of treatment.Keywords
This publication has 11 references indexed in Scilit:
- Retinoids and CancerJournal of Investigative Dermatology, 1985
- Aromatic Retinoid in the Chemoprevention of the Progression of Nevoid Basal‐Cell Carcinoma SyndromeThe Journal of Dermatologic Surgery and Oncology, 1984
- Hematoporphyrin Derivative Photoradiation Therapy in Managing Nevoid Basal-Cell Carcinoma SyndromeArchives of Ophthalmology (1950), 1984
- Nevoid basal cell carcinoma syndromeJournal of the American Academy of Dermatology, 1984
- "The basal-cell nevus" by Howell and Caro, January 1959. Commentary: The nevoid basal cell carcinoma syndromeArchives of Dermatology, 1982
- Chemoprevention of basal cell carcinoma with isotretinoinJournal of the American Academy of Dermatology, 1982
- Therapeutic evaluation of the oral retinoid Ro 10-9359 in several non-psoriatic dermatosesBritish Journal of Dermatology, 1980
- Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatologyCellular and Molecular Life Sciences, 1978
- THE MAMMALIAN URINARY BLADDERAN ACCOMMODATING ORGANBiological Reviews, 1975